CAKE Earnings Day: Short Sellers Dig In as Analysts Raise Targets
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
The Cheesecake Factory reports Q3 results today, and the stock arrives at the print carrying more short pressure than at any point in at least a year, even as analysts have spent the past two weeks lifting their price targets.
Short interest has climbed to 20.8% of the free float, up from around 18.9% at the start of September, with 10.4 million shares now sold short against a stock that has fallen 6.8% over the past week to $108.47. That weekly drop is roughly four times the peer median: closest comparable EAT was essentially flat over the same period, DRI fell less than 2%, and CBRL actually gained ground. The ORTEX short score has edged up to 62.9, its highest reading in the past two weeks, placing CAKE in the bottom 12th percentile of the broader market on short positioning. Despite all of this, the lending market remains loose. Availability is around 493%, meaning nearly five shares sit available to borrow for each one already lent, and the cost to borrow is just 0.42%. Shorts face no mechanical pressure from the borrow side.
The analyst community has been moving in a single direction ahead of today. Six different firms raised price targets in the ten days before the print, including Citigroup lifting to $128 and Oppenheimer to $122, yet most maintained neutral-to-cautious ratings. UBS kept a Sell while raising its target from $60 to $80. Morgan Stanley is at Equal-Weight with an $87 target, well below the current price. The consensus mean sits at $105.93, a shade below where the stock closed yesterday, a rare situation where the Street's central estimate implies modest downside even before the print. The bull case centres on accelerating same-store sales, margin discipline, and growth in younger concepts like Flower Child and North Italia. Bears point to food and wage inflation as a structural margin threat, and to the company's dependence on discretionary spending from higher-income consumers who may pull back if economic conditions deteriorate.
One ownership detail is worth noting. Chairman and CEO David Overton sold 94,145 shares in early August at around $106.27, a transaction worth roughly $10 million. President David Gordon also sold shares on a single day in August, realising close to $3.5 million across two open-market transactions. Neither sale was filed under a pre-arranged 10b5-1 plan, and both occurred close to the current price level. The net insider position over the past 90 days is a sale of roughly 213,000 shares worth $22 million in aggregate. BlackRock added 303,000 shares in the most recent quarter, and Goldman Sachs Asset Management increased its position by more than 1.2 million shares as of October 1, which provides some institutional counterweight to the insider selling.
The print is therefore less a test of whether the Cheesecake Factory can grow same-store sales and more a question of whether Q3 margins came in strong enough to justify a stock that has risen roughly 128% this year, with the heaviest short load in casual dining and a CEO who reduced his stake at these very price levels.
Stocks in this article
See the live data behind this article on ORTEX.
Open CAKE on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 04:16
- Data as of
- 28 Oct 2026, 04:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.